| Primary | Frequency of Prescription Stimulant Diversion | participants will note how many times they have engaged in diversion (i.e., giving away, selling, or trading one's prescribed medication) | There was one fewer participant in the placebo group who responded to the 6-month follow-up survey compared to the 3-month survey. | Posted | | Mean | Standard Deviation | Mean number of times diverted | | baseline, 3-months, 6-months | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
| | | Title | Denominators | Categories |
|---|
| 3-month follow-up | - ParticipantsOG000110
- ParticipantsOG00191
| |
| | Group IDs | Group Description | Statistical Method | Statistical Comment | P-Value | P-Value Comment | Parameter Type | Parameter Value | Dispersion Type | Dispersion Value | Confidence Interval Sides | Confidence Interval % | CI Lower Limit | CI Upper Limit | CI Lower Limit Comment | CI Upper Limit Comment | Estimate Comment | Tested Non-Inferiority | Non-Inferiority Type | Non-Inferiority Comment | Other Analysis Description |
|---|
| | Mixed Models Analysis | | .499 | This test is evaluating change from baseline to 3 months. The p-value was adjusted for the multiple tests (false discovery rate correction). | Cohen's d effect size | .09 | Standard Deviation | 1 | 2-Sided | 95 | -.19 | .37 | | | | | Superiority | | | |
|
| Primary | Intention to Divert Prescription Stimulant Medication | Intentions to divert stimulant medication were assessed with two questions from the Behavior, Expectancies, Attitudes and College Health Questionnaire (Bavarian et al., 2013) adapted to address diversion: "How likely is it that you will give away, [or sell, trade] your stimulant medication in the next three months?". These questions had a four-point response scale (1=very unlikely, 4=very likely). Responses were summed and ranged from 2-8, with 8 indicating the greatest intention to divert (worse outcome). | Because of participants lost to follow-up at each time point, the total number post-intervention; 3-months, and 6-months is slightly lower. | Posted | | Mean | Standard Deviation | units on a scale | | baseline, 3-months, 6-months | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | |
|
| Primary | Frequency of Prescription Stimulant Medication Misuse | participants will indicate any instances of (a) using alternative routes of administration, (b) taking more than your recommended dose, (c) taking someone else's stimulant medication, (d) taking your stimulant with other drugs in order to experience intoxicating effects, or (e) intentionally getting high on your prescribed stimulant medication? | Includes participants who completed the 3- or 6-month follow-up assessment. | Posted | | Mean | Standard Deviation | Number of times misused medication | | baseline, 3-months, 6-months | | | | ID | Title | Description |
|---|
| OG000 | Intervention Group | Group that received the active intervention | | OG001 | Placebo Group | Group that received the placebo presentation. |
| |
| Primary | User Satisfaction With the Simulation/Placebo | We will assess the usefulness, information quality, and interface quality of the simulation using the 13-item Post-Study System Usability Questionnaire. A mean score of 1 indicates lowest level of satisfaction, while a mean score of 7 would indicate the highest level of satisfaction. | | Posted | | Mean | Standard Deviation | units on a scale | | baseline (immediately after simulation or placebo presentation) | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Primary | Usability of the Simulation/Placebo | Participants will respond to 15 items related to the perceived usefulness, user control, and impact of the simulation/placebo. A mean score of 1 would indicate the lowest level of perceived usability; a mean score of 5 would indicate the highest rating of usability. | | Posted | | Mean | Standard Deviation | units on a scale | | baseline (immediately after simulation or placebo presentation) | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Primary | 1 Month Booster Engagement | Booster session #1 is delivered via a slide deck and reviews the key points from the slideshow they viewed at the beginning of the study. Then, participants have to answer 5 questions related to the content. We assess engagement in the online booster session #1 on a 0-5 scale by summing the number of correct answers to the five comprehension questions embedded in the online booster. Each correct item receives one point. Scores ranged from 0 to 5, with 5 indicating the most engagement and accurate understanding of the content. | Number of participants analyzed may differ from overall number due to participants lost at one-month follow-up. | Posted | | Mean | Standard Deviation | score on a scale | | 1 month | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Primary | 2 Month Booster Engagement | Booster session #2 is delivered via a slide deck and reviews the key points from the slideshow they viewed at the beginning of the study. Then, participants have to answer 5 questions related to the content. We assess engagement in the online booster session #2 on a 0-5 scale by summing the number of correct answers to the five comprehension questions embedded in the online booster. Each correct item receives one point. Scores ranged from 0 to 5, with 5 indicating the most engagement and accurate understanding of the content. | Participant numbers are lower than baseline due to participants lost at follow-up. | Posted | | Mean | Standard Deviation | score on a scale | | 2 months | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Secondary | Self-efficacy to Resist Prescription Stimulant Diversion | Participants will rate their confidence to (1) resist giving away their medication, (2) resist selling their medication. These responses, each given on a 5-point scale, were summed and scores ranged from 2 to 10, with 10 indicating the highest level of self-efficacy. | Participant totals may be lower at follow-up due to study attrition. | Posted | | Mean | Standard Deviation | score on a scale | | baseline, 3-months, 6-months | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Secondary | Resistance Strategy Use | At the 3- and 6-month follow up, participants were asked to describe, through an open-ended response, how they responded if they were approached to give away, sell, or trade their medication since the last assessment. The data provided below is the count of participants who provided an open-ended response. | Since not all participants had to turn down requests for their medication, the number of participants below will be smaller than the total. | Posted | | Count of Participants | | Participants | | 3- and 6-months | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Secondary | Perceived Behavioral Norms for Prescription Stimulant Diversion | Participants will indicate, on a scale from 0-100, the percentage of students they believe give away, sell, or trade their prescribed stimulant medication. | Number of participants analyzed reflects the available records at each time point (baseline, 3 months) and may be less than the overall number of participants analyzed. | Posted | | Mean | Standard Deviation | observed percentage of students | | baseline, 3-months | | | | ID | Title | Description |
|---|
| OG000 | Intervention Group | Group that received the active intervention | | OG001 | Placebo Group | Group that received the placebo presentation. |
| |
| Secondary | Perceived Behavioral Norms for Prescription Stimulant Misuse | Participants will indicate, on a scale from 0-100, the percentage of students they believe use stimulant medication in a way it was not prescribed. | Number of participants analyzed reflects the available records at each time point (baseline, 3 months) and may be less than the overall number of participants analyzed. | Posted | | Mean | Standard Deviation | observed percentage of students | | baseline, 3-months | | | | ID | Title | Description |
|---|
| OG000 | Intervention Group | Group that received the active intervention | | OG001 | Placebo Group | Group that received the placebo presentation. |
| |
| Secondary | Perceived Risks From Prescription Stimulant Diversion and Misuse | We will assess perceived legal risks associated with prescription stimulant diversion. We will assess perceived harm from non-medical prescription stimulant use and medical misuse by asking: "How much do people risk harming themselves (physically or in other ways) if they "take stimulants non-medically?" or "use their prescription in a way a prescriber did not intend? Scores ranged from 5 to 20, with higher scores indicating greater perceived risk (better outcome). | Number of participants analyzed reflects the available records at each time point (baseline, 3 months) and may be less than the overall number of participants analyzed. | Posted | | Mean | Standard Deviation | score on a scale | | baseline, 3-months | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | |
|
| Secondary | Communication With Prescriber | Number of times participants communicated with their prescriber regarding their adherence to their prescription and any concerns they have regarding the dose, frequency of administration, and/or side effects in past 90 days. Responses ranged from 0 to 8, with higher scores denoting more communication with a prescriber (better outcome). (Investigator-generated scale) | Participant totals are lower at 3- and 6-month follow-ups due to attrition and some technical difficulties with data collection. | Posted | | Mean | Standard Deviation | number of contacts with prescriber | | baseline, 3-months, 6-months | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Other Pre-specified | Accidental Injuries | Participants will note whether they experienced any accidental injuries in the prior 6 months (e.g., car accidents, burns, etc.). | Participant total at 6-months is lower due to attrition. | Posted | | Mean | Standard Deviation | mean number of accidental injuries | | 6-months | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Other Pre-specified | Other Substance Use | Participants will report any occasions of marijuana, cocaine, heroin, methamphetamine, or hallucinogen use, or other prescription drug misuse in the previous 90 days. | Participant totals at 3- and 6-months are lower due to attrition. | Posted | | Mean | Standard Deviation | mean number of total substance use days | | baseline, 3-months, 6-months | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Other Pre-specified | Attention-Deficit/Hyperactivity Disorder-related Impairment | Using the Impairment Rating Scale, participants reported on the extent to which they experienced problems in social, academic, familial, and vocational circumstances. Responses options ranged from 1=not at all to 7=extreme problem and were averaged to yield an overall impairment score (Range 1-6.25). A lower score indicates less impairment (better outcome), whereas a higher score indicates more impairment (poorer outcome). | Participant total at 6-month follow-up is lower due to attrition. | Posted | | Mean | Standard Deviation | score on a scale | | baseline, 3-months, 6-months | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Other Pre-specified | Conduct Problems | Participants reported on the frequency with which they engaged in 11 problem behaviors before age 18 (0=never, 1=once, 2=twice, 3=three times, 4=more than three times). This scale was adapted from Johnson (1995). Consistent with Garnier (2008), we counted less severe items (e.g., lied, broke rules) as a "1" when rated at least a four. More severe items (e.g., hurt another physically, used a weapon, set a fire) had to occur >2 times to be counted towards the total score. The minimum score was a 0, the maximum an 11. | | Posted | | Mean | Standard Deviation | score on a scale | | baseline | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Post-Hoc | Number of Participants Who Misused Prescribed Stimulant Medication One or More Times in the Past 3-months | Used prescription stimulant medication through alternative routes of administration, took more than their recommended dose of a prescription stimulant, took someone else's stimulant medication, took their stimulant with other drugs in order to experience intoxicating effects, or intentionally got high on their prescribed stimulant medication at least once in the past 3 months | Subsample of participants who completed the 3- and/or 6-month follow-up assessment. | Posted | | Number | | participants | | baseline, 3-months, 6-months | | | | ID | Title | Description |
|---|
| OG000 | Intervention Group | Group that received the active intervention | | OG001 | Placebo Group | Group that received the placebo presentation. |
| |
| Post-Hoc | Number of Participants Who Diverted Prescribed Stimulant Medication One or More Times in the Past 3-months | Gave away, sold, or traded one's stimulant medication at least once in the past 3 months. | Participants who completed the 3- or 6-month follow-up assessments. | Posted | | Count of Participants | | Participants | | baseline, 3-months, 6-months | | | | ID | Title | Description |
|---|
| OG000 | Web-based Simulation Intervention | Participants in this condition will receive psychoeducation about stimulant medication diversion, stimulant medication misuse, and will practice navigating and resisting requests for their medication with a virtual human. Web-based simulation active intervention: This intervention engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. | | OG001 | Placebo Condition | Participants in this condition will learn about psychological conditions that affect college students most often (e.g., depression), causes of those conditions, and pharmacological/behavioral treatments for those conditions. Web-based placebo presentation: This presentation will discuss the prevalence of psychological disorders in college students, their etiologies, psychiatric medications, and students' personal experiences navigating college with a diagnosis of an anxiety and learning disorder, respectively. Attention-deficit/hyperactivity disorder and stimulant medications will be addressed, but diversion and medication misuse will not be discussed. |
|
| Post-Hoc | Proportion of Participants Who Had Any Prescription Stimulant Diversion During the 6-month Study Period | Gave away, sold, or traded one's stimulant medication at least once in the 6-month study period. | Participants who completed the 3- and/or 6-month follow-up assessments. | Posted | | Number | | proportion of participants | | 6 months | | | | ID | Title | Description |
|---|
| OG000 | Intervention Group | Group that received the active intervention | | OG001 | Placebo Group | Group that received the placebo presentation. |
| |
| Post-Hoc | Proportion of Participants Who Had Any Prescription Stimulant Medical Misuse During the 6-month Study Period | Used prescription stimulant medication through alternative routes of administration, took more than their recommended dose of a prescription stimulant, took someone else's stimulant medication, took their stimulant with other drugs in order to experience intoxicating effects, or intentionally got high on their prescribed stimulant medication at least once during the 6-month study period | | Posted | | Number | | proportion of participants | | 6 months | | | | ID | Title | Description |
|---|
| OG000 | Intervention Group | Group that received the active intervention | | OG001 | Placebo Group | Group that received the placebo presentation. |
| |